Optomed’s Financial Statements Bulletin 2020 to be published on 18 Feb 2021

Optomed Plc, Press Release, 11 February 2021 at 14.00, Helsinki

Optomed’s Financial Statements Bulletin 2020 to be published on 18 February 2021

Optomed will publish its Financial Statements Bulletin 2020 on 18 February 2021 approximately at 9.00 EET.

A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest. The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.

Please see the call-in numbers below:

FI +358 9 8562 6300

SE +46 8 505 218 52

UK +44 20 3321 5273

US +1 646 838 1719

FR +33 1 70 99 53 92

The conference id is 554 810 399#.

Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.

Optomed Plc

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358 50 562 4077

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 565 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and Optomed employed 108 professionals the end of 2019.